{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T01:26:45Z","timestamp":1784078805971,"version":"3.55.0"},"reference-count":57,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Chest Medicine"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.ccm.2021.12.001","type":"journal-article","created":{"date-parts":[[2022,2,27]],"date-time":"2022-02-27T06:05:09Z","timestamp":1645941909000},"page":"1-6","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Bronchiectasis from 2012 to 2022"],"prefix":"10.1016","volume":"43","author":[{"given":"James D.","family":"Chalmers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ccm.2021.12.001_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccm.2012.04.002","article-title":"Preface. Bronchiectasis","volume":"33","author":"Metersky","year":"2012","journal-title":"Clin chest Med"},{"issue":"1","key":"10.1016\/j.ccm.2021.12.001_bib2","doi-asserted-by":"crossref","DOI":"10.1183\/23120541.00081-2015","article-title":"The EMBARC European Bronchiectasis Registry: protocol for an international observational study","author":"Chalmers","year":"2016","journal-title":"ERJ Open Res"},{"issue":"1","key":"10.1016\/j.ccm.2021.12.001_bib3","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1183\/13993003.01033-2015","article-title":"Changes in the incidence, prevalence and mortality of bronchiectasis in the UK from 2004 to 2013: a population-based cohort study","volume":"47","author":"Quint","year":"2016","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ccm.2021.12.001_bib4","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.rmed.2016.10.014","article-title":"Prevalence and incidence of bronchiectasis in Catalonia, Spain: a population-based study","volume":"121","author":"Monteagudo","year":"2016","journal-title":"Respir Med"},{"issue":"4","key":"10.1016\/j.ccm.2021.12.001_bib5","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1177\/1479972317709649","article-title":"Prevalence and incidence of noncystic fibrosis bronchiectasis among US adults in 2013","volume":"14","author":"Weycker","year":"2017","journal-title":"Chron Respir Dis"},{"key":"10.1016\/j.ccm.2021.12.001_bib6","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s40248-018-0138-3","article-title":"Get together increase awareness bronchiectasis: a Rep 2(nd) World Bronchiectasis Conf","volume":"13","author":"Aliberti","year":"2018","journal-title":"Multidiscip Respir Med"},{"issue":"4","key":"10.1016\/j.ccm.2021.12.001_bib7","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1183\/09031936.00003709","article-title":"Mortality in bronchiectasis: a long-term study assessing the factors influencing survival","volume":"34","author":"Loebinger","year":"2009","journal-title":"Eur Respir J"},{"issue":"5","key":"10.1016\/j.ccm.2021.12.001_bib8","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.chest.2016.10.055","article-title":"Adult patients with bronchiectasis: a first look at the US bronchiectasis research registry","volume":"151","author":"Aksamit","year":"2017","journal-title":"Chest"},{"key":"10.1016\/j.ccm.2021.12.001_bib9","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/resp.14059","article-title":"Characteristics of bronchiectasis in Korea: first data from the Korean multicentre bronchiectasis Audit and research collaboration registry and comparison with other international registries","volume":"26","author":"Lee","year":"2021","journal-title":"Respirology"},{"issue":"9","key":"10.1016\/j.ccm.2021.12.001_bib10","doi-asserted-by":"crossref","first-page":"e1269","DOI":"10.1016\/S2214-109X(19)30327-4","article-title":"Bronchiectasis in India: results from the European multicentre bronchiectasis Audit and research collaboration (EMBARC) and respiratory research network of India registry","volume":"7","author":"Dhar","year":"2019","journal-title":"Lancet Glob Heal"},{"issue":"5","key":"10.1016\/j.ccm.2021.12.001_bib11","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1164\/rccm.201309-1575OC","article-title":"The bronchiectasis severity index. An international derivation and validation study","volume":"189","author":"Chalmers","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"issue":"12","key":"10.1016\/j.ccm.2021.12.001_bib12","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1136\/thoraxjnl-2016-208481","article-title":"Multidimensional severity assessment in bronchiectasis: an analysis of seven European cohorts","volume":"71","author":"McDonnell","year":"2016","journal-title":"Thorax"},{"issue":"2","key":"10.1016\/j.ccm.2021.12.001_bib13","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1183\/13993003.01312-2015","article-title":"Predicting mortality in bronchiectasis using bronchiectasis severity index and FACED scores: a 19-year cohort study","volume":"47","author":"Ellis","year":"2016","journal-title":"Eur Respir J"},{"issue":"11","key":"10.1016\/j.ccm.2021.12.001_bib14","doi-asserted-by":"crossref","DOI":"10.1164\/rccm.201711-2202OC","article-title":"Characterization of the \u201cfrequent exacerbator phenotype\u201d in bronchiectasis","volume":"197","author":"Chalmers","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"issue":"11","key":"10.1016\/j.ccm.2021.12.001_bib15","first-page":"1602","article-title":"A\u00a0comprehensive analysis of the impact of Pseudomonas aeruginosa Colonization on prognosis in adult bronchiectasis","volume":"12","author":"Finch","year":"2015","journal-title":"Ann Am Thorac Soc"},{"issue":"2","key":"10.1016\/j.ccm.2021.12.001_bib16","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01953-2017","article-title":"The independent contribution of Pseudomonas aeruginosa infection to long-term clinical outcomes in bronchiectasis","volume":"51","author":"Araujo","year":"2018","journal-title":"Eur Respir J"},{"issue":"8","key":"10.1016\/j.ccm.2021.12.001_bib17","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1111\/resp.13280","article-title":"Bronchiectasis in indigenous and non-indigenous residents of Australia and New Zealand","volume":"23","author":"Blackall","year":"2018","journal-title":"Respirology"},{"issue":"1","key":"10.1016\/j.ccm.2021.12.001_bib18","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00535-2020","article-title":"Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS\/ERS\/ESCMID\/IDSA clinical practice guideline","volume":"56","author":"Daley","year":"2020","journal-title":"Eur Respir J"},{"issue":"1","key":"10.1016\/j.ccm.2021.12.001_bib19","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00250-2019","article-title":"Non-tuberculous mycobacterial pulmonary disease","volume":"54","author":"Cowman","year":"2019","journal-title":"Eur Respir J"},{"issue":"1","key":"10.1016\/j.ccm.2021.12.001_bib20","doi-asserted-by":"crossref","DOI":"10.1186\/s12890-018-0638-0","article-title":"Geographic variation in the aetiology, epidemiology and microbiology of bronchiectasis","volume":"18","author":"Chandrasekaran","year":"2018","journal-title":"BMC Pulm Med"},{"issue":"6","key":"10.1016\/j.ccm.2021.12.001_bib21","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1016\/j.chest.2016.12.024","article-title":"Bronchiectasis Rheumatoid overlap syndrome is an independent risk factor for mortality in patients with bronchiectasis: a multicenter cohort study","volume":"151","author":"De Soyza","year":"2017","journal-title":"Chest"},{"issue":"3","key":"10.1016\/j.ccm.2021.12.001_bib22","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00328-2018","article-title":"The overlap between bronchiectasis and chronic airway diseases: state of the art and future directions","volume":"52","author":"Polverino","year":"2018","journal-title":"Eur Respir J"},{"issue":"1","key":"10.1016\/j.ccm.2021.12.001_bib23","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1111\/resp.12875","article-title":"Bronchoarterial ratio in never-smokers adults: Implications for bronchial dilation definition","volume":"22","author":"Diaz","year":"2017","journal-title":"Respirology"},{"issue":"6","key":"10.1016\/j.ccm.2021.12.001_bib24","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00051-2017","article-title":"Pulmonary exacerbation in adults with bronchiectasis: a consensus definition for clinical research","volume":"49","author":"Hill","year":"2017","journal-title":"Eur Respir J"},{"issue":"3","key":"10.1016\/j.ccm.2021.12.001_bib25","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1183\/20734735.005117","article-title":"The European multicentre bronchiectasis Audit and research collaboration (EMBARC): experiences from a successful ERS clinical research collaboration","volume":"13","author":"Chalmers","year":"2017","journal-title":"Breathe (Sheffield, England)"},{"key":"10.1016\/j.ccm.2021.12.001_bib26","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1136\/thx.2010.142778","article-title":"British Thoracic Society guideline for non-CF bronchiectasis","volume":"65","author":"Pasteur","year":"2010","journal-title":"Thorax"},{"issue":"3","key":"10.1016\/j.ccm.2021.12.001_bib27","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00629-2017","article-title":"European Respiratory Society guidelines for the management of adult bronchiectasis","volume":"50","author":"Polverino","year":"2017","journal-title":"Eur Respir J"},{"issue":"4","key":"10.1016\/j.ccm.2021.12.001_bib28","doi-asserted-by":"crossref","first-page":"1802081","DOI":"10.1183\/13993003.02081-2018","article-title":"The clinical impact of Pseudomonas aeruginosa eradication in bronchiectasis in a Dutch referral centre","volume":"53","author":"Pieters","year":"2019","journal-title":"Eur Respir J"},{"issue":"155","key":"10.1016\/j.ccm.2021.12.001_bib29","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0051-2019","article-title":"Is bronchiectasis really a disease?","volume":"29","author":"Shteinberg","year":"2020","journal-title":"Eur Respir Rev"},{"issue":"10150","key":"10.1016\/j.ccm.2021.12.001_bib30","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/S0140-6736(18)31767-7","article-title":"Advances in bronchiectasis: endotyping, genetics, microbiome, and disease heterogeneity","volume":"392","author":"Flume","year":"2018","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.ccm.2021.12.001_bib31","first-page":"6","article-title":"Inflammation: a two-edged sword\u2013the model of bronchiectasis","volume":"147","author":"Cole","year":"1986","journal-title":"Eur J Respir Dis Suppl"},{"issue":"1","key":"10.1016\/j.ccm.2021.12.001_bib32","doi-asserted-by":"crossref","first-page":"1800766","DOI":"10.1183\/13993003.00766-2018","article-title":"Immunological corollary of the pulmonary mycobiome in bronchiectasis: the cameb study","volume":"52","author":"Mac Aogain","year":"2018","journal-title":"Eur Respir J"},{"issue":"4","key":"10.1016\/j.ccm.2021.12.001_bib33","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/s41591-021-01289-7","article-title":"Integrative microbiomics in bronchiectasis exacerbations","volume":"27","author":"Mac Aog\u00e1in","year":"2021","journal-title":"Nat Med"},{"issue":"12","key":"10.1016\/j.ccm.2021.12.001_bib34","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/S2213-2600(14)70213-9","article-title":"The effect of long-term macrolide treatment on respiratory microbiota composition in non-cystic fibrosis bronchiectasis: an analysis from the randomised, double-blind, placebo-controlled BLESS trial","volume":"2","author":"Rogers","year":"2014","journal-title":"Lancet Respir Med"},{"issue":"8","key":"10.1016\/j.ccm.2021.12.001_bib35","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/S2213-2600(20)30557-9","article-title":"The sputum microbiome and clinical outcomes in patients with bronchiectasis: a prospective observational study","volume":"9","author":"Dicker","year":"2021","journal-title":"Lancet Respir Med"},{"issue":"8","key":"10.1016\/j.ccm.2021.12.001_bib36","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/S2213-2600(20)30504-X","article-title":"Neutrophil extracellular traps, disease severity, and antibiotic response in bronchiectasis: an international, observational, multicohort study","volume":"9","author":"Keir","year":"2021","journal-title":"Lancet Respir Med"},{"issue":"6","key":"10.1016\/j.ccm.2021.12.001_bib37","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00303-2019","article-title":"A\u00a0point-of-care neutrophil elastase activity assay identifies bronchiectasis severity, airway infection and risk of exacerbation","volume":"53","author":"Shoemark","year":"2019","journal-title":"Eur Respir J"},{"issue":"6","key":"10.1016\/j.ccm.2021.12.001_bib38","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1164\/rccm.201906-1219OC","article-title":"Airway Mucus Hyperconcentration in non-cystic fibrosis bronchiectasis","volume":"201","author":"Ramsey","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"10.1016\/j.ccm.2021.12.001_bib39","doi-asserted-by":"crossref","first-page":"2002359","DOI":"10.1183\/13993003.02359-2020","article-title":"Topological data analysis reveals genotype-phenotype relationships in primary ciliary dyskinesia","volume":"58","author":"Shoemark","year":"2021","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ccm.2021.12.001_bib40","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.04601-2020","article-title":"The BEAT-PCD (better experimental Approaches to treat primary ciliary dyskinesia) clinical research collaboration","volume":"57","author":"Goutaki","year":"2021","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ccm.2021.12.001_bib41","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01269-2018","article-title":"Treatable traits in bronchiectasis","volume":"52","author":"Boaventura","year":"2018","journal-title":"Eur Respir J"},{"issue":"5","key":"10.1016\/j.ccm.2021.12.001_bib42","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1378\/chest.113.5.1329","article-title":"Treatment of idiopathic bronchiectasis with aerosolized recombinant human DNase I. rhDNase Study Group","volume":"113","author":"O\u2019Donnell","year":"1998","journal-title":"Chest"},{"issue":"12","key":"10.1016\/j.ccm.2021.12.001_bib43","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1001\/jama.2013.2290","article-title":"Effect of long-term, low-dose erythromycin on pulmonary exacerbations among patients with non-cystic fibrosis bronchiectasis: the BLESS randomized controlled trial","volume":"309","author":"Serisier","year":"2013","journal-title":"J\u00a0Am Med Assoc"},{"issue":"12","key":"10.1016\/j.ccm.2021.12.001_bib44","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1001\/jama.2013.1937","article-title":"Effect of azithromycin maintenance treatment on infectious exacerbations among patients with non-cystic fibrosis bronchiectasis: the BAT randomized controlled trial","volume":"309","author":"Altenburg","year":"2013","journal-title":"JAMA"},{"issue":"9842","key":"10.1016\/j.ccm.2021.12.001_bib45","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/S0140-6736(12)60953-2","article-title":"Azithromycin for prevention of exacerbations in non-cystic fibrosis bronchiectasis (EMBRACE): a randomised, double-blind, placebo-controlled trial","volume":"380","author":"Wong","year":"2012","journal-title":"Lancet (London, England)"},{"issue":"10","key":"10.1016\/j.ccm.2021.12.001_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-2600(19)30191-2","article-title":"Long-term macrolide antibiotics for the treatment of bronchiectasis in adults: an individual participant data meta-analysis","volume":"7","author":"Chalmers","year":"2019","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.ccm.2021.12.001_bib47","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/1745-6215-12-94","article-title":"Randomized placebo-controlled trial on azithromycin to reduce the morbidity of bronchiolitis in Indigenous Australian infants: rationale and protocol","volume":"12","author":"Chang","year":"2011","journal-title":"Trials"},{"issue":"9","key":"10.1016\/j.ccm.2021.12.001_bib48","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/S2213-2600(14)70165-1","article-title":"Aztreonam for inhalation solution in patients with non-cystic fibrosis bronchiectasis (AIR-BX1 and AIR-BX2): two randomised double-blind, placebo-controlled phase 3 trials","volume":"2","author":"Barker","year":"2014","journal-title":"Lancet Respir Med"},{"issue":"1","key":"10.1016\/j.ccm.2021.12.001_bib49","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02052-2017","article-title":"Respire 1: a phase III placebo-controlled randomised trial of ciprofloxacin dry powder for inhalation in non-cystic fibrosis bronchiectasis","volume":"51","author":"De Soyza","year":"2018","journal-title":"Eur Respir J"},{"issue":"3","key":"10.1016\/j.ccm.2021.12.001_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-2600(18)30427-2","article-title":"Inhaled liposomal ciprofloxacin in patients with non-cystic fibrosis bronchiectasis and chronic lung infection with Pseudomonas aeruginosa (ORBIT-3 and ORBIT-4): two phase 3, randomised controlled trials","volume":"7","author":"Haworth","year":"2019","journal-title":"Lancet Respir Med"},{"issue":"10","key":"10.1016\/j.ccm.2021.12.001_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-2600(19)30185-7","article-title":"The efficacy and safety of inhaled antibiotics for the treatment of bronchiectasis in adults: a systematic review and meta-analysis","volume":"7","author":"Laska","year":"2019","journal-title":"Lancet Respir Med"},{"issue":"1","key":"10.1016\/j.ccm.2021.12.001_bib52","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01926-2017","article-title":"Long-term benefits of airway clearance in bronchiectasis: a randomised placebo-controlled trial","volume":"51","author":"Munoz","year":"2018","journal-title":"Eur Respir J"},{"issue":"22","key":"10.1016\/j.ccm.2021.12.001_bib53","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1056\/NEJMoa2021713","article-title":"Phase 2 trial of the DPP-1 inhibitor Brensocatib in bronchiectasis","volume":"383","author":"Chalmers","year":"2020","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.ccm.2021.12.001_bib54","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1136\/thoraxjnl-2014-205918","article-title":"Quality of Life Questionnaire-Bronchiectasis: final psychometric analyses and determination of minimal important difference scores","volume":"70","author":"Quittner","year":"2015","journal-title":"Thorax"},{"key":"10.1016\/j.ccm.2021.12.001_bib55","article-title":"Validation of the Bronchiectasis Impact Measure (BIM) - a novel patient reported outcome measure","author":"Crichton","year":"2020","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ccm.2021.12.001_bib56","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.rmed.2018.10.030","article-title":"Quality control for multiple breath washout tests in multicentre bronchiectasis studies: experiences from the BRONCH-UK clinimetrics study","volume":"145","author":"O\u2019Neill","year":"2018","journal-title":"Respir Med"},{"issue":"151","key":"10.1016\/j.ccm.2021.12.001_bib57","doi-asserted-by":"crossref","first-page":"180108","DOI":"10.1183\/16000617.0108-2018","article-title":"A\u00a0systematic review of pharmacotherapeutic clinical trial end-points for bronchiectasis in adults","volume":"28","author":"Crichton","year":"2019","journal-title":"Eur Respir Rev [Internet]"}],"container-title":["Clinics in Chest Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S027252312101248X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S027252312101248X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T01:14:28Z","timestamp":1759454068000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S027252312101248X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":57,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["S027252312101248X"],"URL":"https:\/\/doi.org\/10.1016\/j.ccm.2021.12.001","relation":{},"ISSN":["0272-5231"],"issn-type":[{"value":"0272-5231","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bronchiectasis from 2012 to 2022","name":"articletitle","label":"Article Title"},{"value":"Clinics in Chest Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ccm.2021.12.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}